These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 24743332)

  • 1. Increased microRNA-155 and decreased microRNA-146a may promote ocular inflammation and proliferation in Graves' ophthalmopathy.
    Li K; Du Y; Jiang BL; He JF
    Med Sci Monit; 2014 Apr; 20():639-43. PubMed ID: 24743332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of miR-146a in the Regulation of Inflammation in an In Vitro Model of Graves' Orbitopathy.
    Jang SY; Chae MK; Lee JH; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4027-34. PubMed ID: 27494344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with Graves' orbitopathy.
    Jang SY; Park SJ; Chae MK; Lee JH; Lee EJ; Yoon JS
    Br J Ophthalmol; 2018 Mar; 102(3):407-414. PubMed ID: 29101123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased microRNA-146a in CD4+T cells promote ocular inflammation in thyroid-associated ophthalmopathy by targeting NUMB.
    Hu ZJ; He JF; Li KJ; Chen J; Xie XR
    Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1803-1809. PubMed ID: 28485799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-146a downregulates the production of hyaluronic acid and collagen I in Graves' ophthalmopathy orbital fibroblasts.
    Liu W; Ma C; Li HY; Chen L; Yuan SS; Li KJ
    Exp Ther Med; 2020 Nov; 20(5):38. PubMed ID: 32952629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves' ophthalmopathy.
    Wei H; Guan M; Qin Y; Xie C; Fu X; Gao F; Xue Y
    Endocr J; 2014; 61(11):1087-92. PubMed ID: 25100151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
    Dik WA; Virakul S; van Steensel L
    Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of MicroRNA-146a/Notch2 Signaling Regulating IL-6 in Graves Ophthalmopathy.
    Wang N; Chen FE; Long ZW
    Cell Physiol Biochem; 2017; 41(4):1285-1297. PubMed ID: 28278511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases?
    Wall JR; Lahooti H
    Endokrynol Pol; 2010; 61(2):222-7. PubMed ID: 20464711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves' Ophthalmopathy.
    Virakul S; Somparn P; Pisitkun T; van der Spek PJ; Dalm VASH; Paridaens D; van Hagen PM; Hirankarn N; Palaga T; Dik WA
    Front Endocrinol (Lausanne); 2020; 11():619989. PubMed ID: 33658982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSHR Signaling Stimulates Proliferation Through PI3K/Akt and Induction of miR-146a and miR-155 in Thyroid Eye Disease Orbital Fibroblasts.
    Woeller CF; Roztocil E; Hammond C; Feldon SE
    Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4336-4345. PubMed ID: 31622470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biomarkers of Graves' ophthalmopathy.
    Longo CM; Higgins PJ
    Exp Mol Pathol; 2019 Feb; 106():1-6. PubMed ID: 30414981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy.
    Feldon SE; Park DJ; O'Loughlin CW; Nguyen VT; Landskroner-Eiger S; Chang D; Thatcher TH; Phipps RP
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3913-21. PubMed ID: 16249464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-183 and microRNA-96 are associated with autoimmune responses by regulating T cell activation.
    Thiel J; Alter C; Luppus S; Eckstein A; Tan S; Führer D; Pastille E; Westendorf AM; Buer J; Hansen W
    J Autoimmun; 2019 Jan; 96():94-103. PubMed ID: 30201436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of oculometric variables in Graves' ophthalmopathy.
    Miot HA; Fernandes LP; Jorge EN; Pivotto DR; Nogueira CR; Mazeto GM
    Clinics (Sao Paulo); 2009; 64(9):885-9. PubMed ID: 19759882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy.
    Tong BD; Xiao MY; Zeng JX; Xiong W
    Mol Vis; 2015; 21():324-34. PubMed ID: 25873777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Insights Into the Role of Epigenetics and Gut Microbiome in the Pathogenesis of Graves' Ophthalmopathy.
    Wang Y; Ma XM; Wang X; Sun X; Wang LJ; Li XQ; Liu XY; Yu HS
    Front Endocrinol (Lausanne); 2021; 12():788535. PubMed ID: 35069441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
    Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
    Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase.
    Choi YJ; Kim C; Choi EW; Lee SH; Chae MK; Jun HO; Kim BY; Yoon JS; Jang SY
    PLoS One; 2022; 17(8):e0270416. PubMed ID: 35980936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms That Underly T Cell Immunity in Graves' Orbitopathy.
    Fang S; Lu Y; Huang Y; Zhou H; Fan X
    Front Endocrinol (Lausanne); 2021; 12():648732. PubMed ID: 33868176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.